Further investigations revealed that IL-33 induces the activation of the ERK1/2 pathway via the ST2 receptor, subsequently increasing the secretion of MMP-3 and IL-6 to promote the invasion and migration of GC cells12. The gene discussed is IL33; the disease is gastric cancer.